FDA Inspection 976279 — Nexus Pharmaceuticals, LLC

Nexus Pharmaceuticals, LLC — FEI 3005191225

The FDA completed an inspection of Nexus Pharmaceuticals, LLC on Jun 29, 2016 in Lincolnshire, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lincolnshire, IL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed